scholarly journals PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

2021 ◽  
Vol 17 (6) ◽  
pp. 1447-1547
Author(s):  
Maciej Banach ◽  
Paweł Burchardt ◽  
Krzysztof Chlebus ◽  
Piotr Dobrowolski ◽  
Dariusz Dudek ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Primary Prevention ◽  
Rare Diseases ◽  
Unmet Needs ◽  
Familial Hypercholesterolaemia ◽  
Cholesterol Metabolism ◽  
Coordinated Care ◽  
Scientific Societies ◽  
Lipid Disorders ◽  
Primary Prevention Program

In Poland there are still nearly 20 million individuals with hypercholesterolaemia, most of them are unaware of their condition; that is also why only ca. 5% of patients with familial hypercholesterolaemia have been diagnosed; that is why other rare cholesterol metabolism disorders are so rarely diagnosed in Poland. Let us hope that these guidelines, being an effect of work of experts representing 6 main scientific societies, as well as the network of PoLA lipid centers being a part of the EAS lipid centers, certification of lipidologists by PoLA, or the growing number of centers for rare diseases, with a network planned by the Ministry of Health, improvements in coordinated care for patients after myocardial infarction (KOS-Zawał), reimbursement of innovative agents, as well as introduction in Poland of an effective primary prevention program, will make improvement in relation to these unmet needs in diagnostics and treatment of lipid disorders possible.

Pilot of a Diabetes Primary Prevention Program in a Hard-to-Reach, Low-Income, Immigrant Hispanic Population

2010 ◽  
Vol 13 (5) ◽  
pp. 906-913 ◽  
Author(s):  
Ann V. Millard ◽  
Margaret A. Graham ◽  
Xiaohui Wang ◽  
Nelda Mier ◽  
Esmeralda R. Sánchez ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Low Income ◽  
Prevention Program ◽  
Hispanic Population ◽  
Primary Prevention Program

scholarly journals Diabetes primary prevention program: New insights from data analysis of recruitment period

2017 ◽  
Vol 34 (1) ◽  
pp. e2943 ◽  
Author(s):  
Juan J. Gagliardino ◽  
Jorge F. Elgart ◽  
Marcelo Bourgeois ◽  
Graciela Etchegoyen ◽  
Gabriel Fantuzzi ◽  
...  
Keyword(s):  
Data Analysis ◽  
Primary Prevention ◽  
Prevention Program ◽  
Primary Prevention Program ◽  
Recruitment Period

scholarly journals Homozygous Familial Hypercholesterolaemia with Valvular Aortic Stenosis and Significant Coronary Artery Disease: A Case Report

2014 ◽  
Vol 6 (2) ◽  
pp. 180-183
Author(s):  
B Dutta ◽  
AKMM Islam ◽  
M Ullah ◽  
A Zaman ◽  
KK Karmakar ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Coronary Artery Disease ◽  
Aortic Stenosis ◽  
Familial Hypercholesterolaemia ◽  
Genetic Disorder ◽  
Significant Coronary Artery Disease ◽  
Rare Presentation ◽  
Valvular Aortic Stenosis ◽  
Homozygous Familial Hypercholesterolaemia ◽  
Artery Disease

Homozygous Familial Hypercholesterolaemia is a genetic disorder which usually presents with early cardiovascular disease ranging from premature ischaemic disease, including myocardial infarction to aortic root stenosis. A 21 year old Bangladeshi male presented with exertional chest pain and breathlessness. He was diagnosed as a case of Homozygous Familial Hypercholesterolaemia. His angina symptoms were due to underlying valvular aortic stenosis which is a rare presentation of Homozygous Familial Hypercholesterolaemia. DOI: http://dx.doi.org/10.3329/cardio.v6i2.18365 Cardiovasc. j. 2014; 6(2): 180-183

scholarly journals Clinical case of myocardial infarction with unspecified familial hypercholesterolemia

2022 ◽  
Vol 17 (4) ◽  
pp. 74-78
Author(s):  
N. G. Lozhkina ◽  
A. N. Spiridonov
Keyword(s):  
Myocardial Infarction ◽  
Familial Hypercholesterolemia ◽  
Clinical Case ◽  
Autosomal Dominant ◽  
Clinical Symptoms ◽  
Cholesterol Metabolism ◽  
Single Gene ◽  
Low Density Lipoproteins ◽  
Dominant Disease ◽  
Appropriate Therapy

Familial hypercholesterolemia is a hereditary autosomal dominant disease characterized by a violation of cholesterol metabolism. This nosology was first described in the late 1930s by the Norwegian clinician Karl Moeller, he proposed the idea that hypercholesterolemia and tendon xanthomas are associated with cardiovascular diseases through the inheritance of a single gene. In 1964, two clinical phenotypes of familial hypercholesterolemia were discovered: heterozygous and homozygous, associated with an unfavorable prognosis. To date, it is known that the long-running process of accumulation of low-density lipoproteins in the intima of blood vessels may not have clinical symptoms for many years due to the developed system of collaterals and the absence of hemodynamically significant stenosis. However, without timely diagnosis and appropriate therapy, this condition inevitably leads to the development of a cardiovascular event. The article presents a clinical case demonstrating the development of myocardial infarction in a patient with a late diagnosis of this disease.

Sign in / Sign up

Export Citation Format

Share Document